REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Zdrowegeny.Pl Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmacies and Drug Stores | Department Stores | Data Processing, Hosting, and Related Services | Internet Publishing and Broadcasting and Web Search Portals | Advertising Agencies | All Other Miscellaneous Ambulatory Health Care Services | Other Personal Care Services
Full name: Zdrowegeny.Pl Sp. z o.o. Profile Updated: May 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Zdrowegeny.pl is a company that offers the Genodiet Completo study, which evaluates metabolic processes of vitamin D, folic acid, and calcium. They also provide the GENOdiagDIETA test, which analyzes pholic acid metabolism and vitamins D, B2, and E, as well as the body's elimination of free radicals and toxins.

Headquarters
Ul. Jutrzenki 100
Warsaw; Mazowieckie; Postal Code: 02-230

Contact Details: Purchase the Zdrowegeny.Pl Sp. z o.o. report to view the information.

Website: https://zdrowegeny.pl/polityka-prywatnosci

Basic Information
Total Employees:
Purchase the Zdrowegeny.Pl Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Zdrowegeny.Pl Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Zdrowegeny.Pl Sp. z o.o. report to view the information.
Incorporation Date:
October 05, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Zdrowegeny.Pl Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-18.64%▼
Total operating revenue
-18.89%▼
Operating profit (EBIT)
59.41%▲
Net Profit (Loss) for the Period
59.38%▲
Total assets
-43.34%▼
Total equity
-140.72%▼
Operating Profit Margin (ROS)
8.7%▲
Net Profit Margin
8.75%▲
Return on Equity (ROE)
-287.97%▼
Quick Ratio
-0.35%▼
Cash Ratio
-0.3%▼

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Selvita Services Sp. z o.o.
 
Sartorius Stedim Poland Sp. z o.o.
Polpharma Biologics S.A.
 
Ryvu Therapeutics S.A.
Bs Biotechna S.A.
 
Rdls Sp. z o.o.
Biolabinvest Sp. z o.o.
 
Orion Biotechnology Polska Sp. z o.o.
Ecoversea Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo